Stories

 

Read success stories about NRC research, and how our work contributes to the success of our clients and partners.

 

""

- Ottawa, Ontario

Research Centre: Digital Technologies, Human Health Therapeutics
Industry: Artificial Intelligence and Machine Learning, Health and Bio-sciences
""

- Ottawa, Ontario

Research Centre: Human Health Therapeutics, Metrology
Industry: Biopharmaceuticals

- Ottawa, Ontario

Research Centre: Advanced Electronics and Photonics, Digital Technologies, Herzberg Astronomy and Astrophysics, Human Health Therapeutics
Industry: Pharmaceutical Manufacturing, Communication Technologies, Biopharmaceuticals, Astronomy
""

- Ottawa, Ontario

Research Centre: Human Health Therapeutics
Industry: Health and Bio-sciences

- Ottawa,

Research Centre: Aquatic and Crop Resource Development, Automotive and Surface Transportation, Design and Fabrication services, Human Health Therapeutics, Industrial Research Assistance Program, Medical Devices
Industry: Health and Bio-sciences
Luke Masson

- Montreal, Quebec

Research Centre: Human Health Therapeutics, Medical Devices
Industry: Health and Bio-sciences
""

- Montreal, Quebec

Research Centre: Human Health Therapeutics
Industry: Health and Bio-sciences
""

- Ottawa, Ontario

Research Centre: Human Health Therapeutics
As the leading cause of birth defects, cytomegalovirus (CMV) affects more children than Fetal Alcohol Syndrome or Down Syndrome and infects up to 90 percent of adults worldwide. Typically unnoticed in healthy people, CMV can be life-threatening for the immunocompromised, which includes persons infected with HIV, organ transplant recipients and most commonly, newborn infants.
""

- Ottawa, Ontario

Research Centre: Human Health Therapeutics
The inner workings of the human brain hold mysteries that continue to challenge medical researchers and scientists around the world. One such mystery is determining how to delay the progression of brain diseases such as Alzheimer’s, Multiple Sclerosis (MS) and Parkinson’s. Now an important Canadian research breakthrough may have found the key to slowing their spread.
""

- Montréal, Quebec

Research Centre: Human Health Therapeutics
When Vancouver, B.C.'s Zymeworks Inc. opened its doors in 2003, the biotherapeutics company was determined to address a need in the pharmaceutical and chemical markets that was not being served by the existing approaches to protein simulation and engineering. Committed to developing best-in-class antibody and protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases, Zymeworks set out to create a platform that was commercially relevant and that reflected the most recent advances in protein biochemistry and computing architecture.